MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. - Wikidata - wikimedia - TriplyDB

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

http://www.wikidata.org/entity/Q34983172

about

CIP2A expression is increased in prostate cancer IκB kinases increase Myc protein stability and enhance progression of breast cancer cells Identification of protein interactions involved in cellular signaling Protein Phosphatase 2A as a Therapeutic Target in Acute Myeloid Leukemia LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential CIP2A down regulation enhances the sensitivity of pancreatic cancer cells to gemcitabine.The Basic Biology of PP2A in Hematologic Cells and Malignancies Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells Overexpression and small molecule-triggered downregulation of CIP2A in lung cancer Regulation of c-Myc Protein Abundance by a Protein Phosphatase 2A-Glycogen Synthase Kinase 3β-Negative Feedback Pathway.Ethoxysanguinarine Induces Inhibitory Effects and Downregulates CIP2A in Lung Cancer Cells.Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer.Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis.Genomic and genetic alterations influence the progression of gastric cancer.Cancerous inhibitor of protein phosphatase 2A mediates bortezomib-induced autophagy in hepatocellular carcinoma independent of proteasome.CIP2A influences survival in colon cancer and is critical for maintaining Myc expression High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer.Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer.Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.Prognostic role of CIP2A expression in serous ovarian cancer Afatinib induces apoptosis in NSCLC without EGFR mutation through Elk-1-mediated suppression of CIP2A PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival.Cancerous inhibitor of protein phosphatase 2A contributes to human papillomavirus oncoprotein E7-induced cell proliferation via E2F1.Mouse model for probing tumor suppressor activity of protein phosphatase 2A in diverse signaling pathways.CIP2A is a target of bortezomib in human triple negative breast cancer cells.CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations.Relationship between CIP2A expression, and prognosis and MDR-related proteins in patients with advanced gastric cancer.CIP2A protein expression in high-grade, high-stage bladder cancer.Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1.Aberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer.Ets1 and Elk1 transcription factors regulate cancerous inhibitor of protein phosphatase 2A expression in cervical and endometrial carcinoma cells.PP2A Counterbalances Phosphorylation of pRB and Mitotic Proteins by Multiple CDKs: Potential Implications for PP2A Disruption in Cancer Cancerous inhibitor of protein phosphatase 2A determines bortezomib-induced apoptosis in leukemia cells.Cancerous Inhibitor of PP2A Silencing Inhibits Proliferation and Promotes Apoptosis in Human Multiple Myeloma Cells.Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells.Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells.

P2860

Q21198842-3ADDA712-43C6-4FA3-8363-542D1C09DBE1 Q24302544-CC8A9A94-E3C7-4312-9EAB-7ACFD03E9ED2 Q24601574-6EE8B6C3-4B0A-4279-BFB4-C430D7F4BDAD Q26752430-164785BD-1AAF-45BA-8ADA-0A82EF41E054 Q26865711-3C6530F4-13FC-41C7-8398-BC0369FBFCB9 Q27853345-222EE669-BDD3-4507-A638-C61521E3A3E5 Q28088697-B17B7D8D-CBB0-40BE-AA17-48F348AC4902 Q28299365-F15B6A94-CC6B-41A2-A13C-85F265AE083F Q28478368-121263DD-A303-404C-9842-0D00470FD7DA Q30464719-7EC8A450-67DA-47A0-A139-E2221B71F004 Q33636463-016A32B5-79DD-4EC5-BCDC-272948102487 Q33712856-945C4C8B-41AB-4655-B151-06944D0522A6 Q33835127-C3F3F9C7-0126-49D3-ADA2-3F923BDF0E6D Q33895872-7D892F37-2548-47FC-AFEB-6847B033875C Q34043449-06FFE9E9-E1F1-4C95-8934-531845A9FFD3 Q34138056-A9108FE0-D40F-469D-9313-BE0F7489D46B Q34497423-79270662-75E1-4506-A929-C9D595084D39 Q34577215-08A4AE61-D181-4676-A76C-2D63D5581FAC Q35009096-BFCBD60F-CE6A-433E-A4A9-CE02110527F8 Q35034737-A49B75D4-08B1-4FF6-B9E9-AF97FA7EB568 Q35055737-B4DB62F0-120A-4778-94BA-BAF8AA7A4F41 Q35059164-5EDB769E-8B94-416B-866B-3415803264FB Q35263210-3430D350-B687-4F20-807C-9F6B7011FDDE Q35273471-45381C28-54A7-4048-A56D-0FC367F10D59 Q35541658-C6A21C33-A73E-411B-BC1F-93BECFF13BD1 Q35653981-F6C049CC-CF5B-46E2-B4EF-DBC77B869AFB Q35741656-C5CCB444-B977-44C7-B65A-77822681D982 Q35859963-8FFC213F-203C-425F-A9C7-DAD299B5D07C Q36245640-A5BB772C-785F-45C1-BC7F-8276CF5666D6 Q36260616-179D94EC-12C9-4BA7-BD92-4CBFDDFB7AC1 Q36464767-2FCB8978-55F1-4839-A11D-99AF80245524 Q36530648-EF5424EA-2390-4A6B-8649-1659FA28E1E6 Q36609038-ABC90D1D-B024-4271-9804-3F91D72AB9F6 Q36689020-00F8B1FB-B8F6-4136-B002-D294D58DFBC7 Q36777896-B296A26D-E04B-4DC5-AC91-12A5D69A5517 Q36796453-AAFA828F-3210-4760-A6CD-6C5F9BC614A3 Q36805842-23390263-EE91-4B20-8836-FD8E8AE2C1C5 Q36814489-AEAFA473-F446-43AA-8773-A745F175E659 Q36962531-DB5CC294-9456-4EAB-8132-A4BE94049CA6 Q37103978-A5B3A399-0B8E-4295-AEEB-B3256327EEF1

P2860

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

http://www.wikidata.org/entity/Q34983172

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

@ast

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

@en

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

@nl

type

label

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

@ast

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

@en

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

@nl

prefLabel

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

@ast

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

@en

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

@nl

P1433

Q34983172-E2C4B4C3-F218-417B-AB6E-89FA40640013

P1476

Q34983172-D2ED7EE6-5CAE-4FC9-8BD2-786333B10E70

P2093

Q34983172-3B247928-F643-4A62-B292-7CEF73B10893

Q34983172-3E70EB05-FADC-43CA-A547-2416C669AC49

Q34983172-401A7AE0-5A33-480D-AAD4-7DC83D94A81F

Q34983172-59898AF7-99F7-4BEC-ACBF-C01866459AC5

Q34983172-7DD2DD9E-663B-4BFB-8F20-7C5A6390521A

Q34983172-8F040BE8-4EEA-4249-B640-825FBDA44898

Q34983172-91107EB1-2836-4565-A081-75846F8DD4CE

Q34983172-B25E21FD-9150-48FF-872D-652BF86E5C1F

Q34983172-E0A6B1B4-11C6-43EC-80A0-CA8D5BD6357A

Q34983172-F430EDCB-9F87-4FBD-8062-C3714A087844

P2860

Q34983172-0C25BB62-351C-4466-882C-262A4192A9D9

Q34983172-2516C438-F0B2-4847-B9DA-7CCF28E4252B

Q34983172-2A3D5055-EC5E-42A2-8C9E-0E732654A32D

Q34983172-2F38A535-AB37-474C-8540-79B67582A0BD

Q34983172-38845120-7763-47A7-81D0-1170FB6E8BC5

Q34983172-48BA4F04-F4DC-4923-A31A-82AEE020C0DB

Q34983172-4D680237-B409-4FED-BDA8-F4A486115A9B

Q34983172-4F47AC82-A36D-4D9F-9AD1-BD89D84CB3E4

Q34983172-509D8CAF-3A66-4968-B3A2-151F57A7BF77

Q34983172-55D850D1-7CB6-4A77-819A-63849553B224

P304

Q34983172-1E75B6B2-F549-4CAC-964D-BEA8B754621B

P31

Q34983172-BE2D3BF5-C2BA-43BE-B021-3F761D896111

P356

Q34983172-EF0E8881-EF23-43D0-A5BD-710F1F05AC48

P407

Q34983172-B3B871B2-7586-4D22-99AD-D2B39AC19068

P433

Q34983172-958A78E9-7370-48D9-8B06-6D16F607B77C

P478

Q34983172-1941EEA2-0F94-4741-A9B4-1978E7AF34D8

P50

Q34983172-3609035F-7A9E-4A97-AB11-A31F53051710

Q34983172-C77580DD-13CD-4172-8A78-EB761C8DA119

P577

Q34983172-CD81C9A8-176E-4A76-8505-CE7A932074DD

P5875

Q34983172-613ED101-ADC2-4EE7-A7AD-AF0B35BA5EDD

P698

Q34983172-731008D6-14BE-4510-B96A-30A50834E1BC

P356

P1433

Journal of the National Cancer Institute

P1476

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer

@en

P2093

Anchit Khanna

http://www.w3.org/2001/XMLSchema#string

Annabrita Hemmes

http://www.w3.org/2001/XMLSchema#string

Ari Ristimäki

http://www.w3.org/2001/XMLSchema#string

Caj Haglund

http://www.w3.org/2001/XMLSchema#string

Daniel J Murphy

http://www.w3.org/2001/XMLSchema#string

Gerard I Evan

http://www.w3.org/2001/XMLSchema#string

Jan-Patrik Wiksten

http://www.w3.org/2001/XMLSchema#string

Melissa R Junttila

http://www.w3.org/2001/XMLSchema#string

Mikael Lundin

http://www.w3.org/2001/XMLSchema#string

Siina Junnila

http://www.w3.org/2001/XMLSchema#string

P2860

Mammalian homologues of the plant Tousled gene code for cell-cycle-regulated kinases with maximal activities linked to ongoing DNA replication

The ubiquitin-specific protease USP28 is required for MYC stability

CIP2A inhibits PP2A in human malignancies

Nonparametric Estimation from Incomplete Observations

Global cancer statistics, 2002

c-MYC: more than just a matter of life and death

Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability

Improved low molecular weight Myc-Max inhibitors.

c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells

PP2A: unveiling a reluctant tumor suppressor.

P304

793-805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJP103

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Camilla Böckelman

Jukka Westermarck

P577

2009-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26242399

http://www.w3.org/2001/XMLSchema#string

P698

19470954

http://www.w3.org/2001/XMLSchema#string